GlaxoSmithKline (GSK) is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history.
The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).
The settlement will cover criminal fines as well as civil settlements with the federal and state governments.
The case concerns the drugs Paxil, Wellbutrin and Avandia.
Deputy US Attorney General James Cole told a news conference in Washington DC that the settlement was "unprecedented in both size and scope".
GSK, one of the world's largest healthcare and pharmaceuticals companies, admitted to promoting antidepressants Paxil and Wellbutrin for unapproved uses, including treatment of children and adolescents. Full story...
Related posts:
The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).
The settlement will cover criminal fines as well as civil settlements with the federal and state governments.
The case concerns the drugs Paxil, Wellbutrin and Avandia.
Deputy US Attorney General James Cole told a news conference in Washington DC that the settlement was "unprecedented in both size and scope".
GSK, one of the world's largest healthcare and pharmaceuticals companies, admitted to promoting antidepressants Paxil and Wellbutrin for unapproved uses, including treatment of children and adolescents. Full story...
Related posts:
- Big Pharma routinely suppresses data from clinical trials...
- Allergy fears halt distribution of GlaxoSmithKline swine flu vaccine in Canada...
- How Big Pharma dopes and dupes...
- BBC accused of propaganda for drug company...
- 70% of all doctors and nurses do not get the annual flu vaccine...
- Drug companies lavish free oversees trips and sports tickets on NHS bosses...
- 84% of doctors still sucking up to drug companies...
- Anger over secret drug trials on Indian children...
- U.S. pharmaceutical companies testing drugs on India's poor...
No comments:
Post a Comment